@jnahmias1@MelVegCen We believe that Biotube will lead to a change in the mindset of surgeons by providing a small-diameter vascular prosthesis, which has been considered impossible until now.
@jnahmias1@MelVegCen My name is Yasuhide Nakayama and I am a bioengineering researcher who has been developing in-body tissue architecture technology including Biotube for 20 years. Currently, I am the CTO of Biotube Co., Ltd.
@FLareyre@rhigashita@EJVES_ESVS@MelVegCen We think that Biotubes can be made in one month, just like animal experiments. Clinically, the implantation period was extended to 2 months to avoid incomplete biotube formation. This clinical trial is FIH.
@MelVegCen@EJVES_ESVS Biotube transformed into an autologous blood vessel within 3 months after implantation. Animal experiments with goats showed no increase in diameter for more than a year.
On Thursday 29th Sep 15:00-15:30 CET LIVE TWITTER #EJVESforum discussion on biograft research, with authors of "Acute Phase Pilot Evaluation of Small Diameter Long iBTA Induced Vascular Graft βBiotubeβ in a Goat Model".
https://t.co/JuurMonwfh
Join us!!
#openaccess@MelVegCen